BIOMAT Database Logo BIOMAT Database Logo

[beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group]. 2002

Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Juntendo University.

beta-Lactamase production and susceptibility to an assortment of antimicrobial agents were examined in 9,483 strains of organisms isolated from clinical materials obtained from inpatients and outpatients at 104 institutions throughout Japan from December 1999 to February 2000. The organisms were Staphylococcus aureus, 1,369 strains, including 847 methicillin-resistant (MRSA) strains; Enterococcus faecalis, 735 strains; Enterococcus faecium, 302 strains; Moraxella (Branhamella) catarrhalis, 730 strains; Haemophilus influenzae, 1,142 strains; Escherichia coli, 1,276 strains; Klebsiella pneumoniae, 1,058 strains; Enterobacter cloacae, 772 strains; Serratia marcescens, 847 strains; and Pseudomonas aeruginosa, 1,252 strains. The 23 antimicrobial agents used were ampicillin, sulbactam/ampicillin, clavulanic acid/amoxicillin, oxacillin, piperacillin, cefazolin, cefotiam, cefmetazole, cefoperazone, sulbactam/cefoperazone, cefotaxime, ceftazidime, cefepime, cefpodoxime, imipenem, gentamicin, arbekacin, clarithromycin, minocycline, chloramphenicol, vancomycin, teicoplanin, and levofloxacin. Antimicrobial agents appropriate for each organism were used. Among S. aureus strains, 61.9% were MRSA, and 62.3% were positive for beta-lactamase. Among the MRSA strains, none was resistant to vancomycin or teicoplanin, and only 3% were resistant to arbekacin. There was no vancomycin resistance in the Enterococcus strains. Only 0.1% of E. faecalis strains were ampicillin-resistant. Among the M. catarrhalis strains, 97.5% produced beta-lactamase, while among the H. influenzae strains, 8.5% produced beta-lactamase and 14.5% were beta-lactamase-negative and ampicillin-resistant (BLNAR). Among the Enterobacteriaceae and P. aeruginosa strains, there were 20 (E. coli; 7/1,276, K. pneumoniae; 13/1,058) that produced extended-spectrum beta-lactamases (ESBLs), and 11 that produced class B beta-lactamases. Multiple drug resistance was advanced in every species, and organisms resistant to 7 or more common antimicrobial agents were isolated. The best combination of antimicrobial agent and beta-lactamase inhibitor was sulbactam/cefoperazone. Sulbactam/cefoperazone, cefepime, and imipenem still have excellent antimicrobial activity. Rates of resistance to each antimicrobial agent differed more among institutions than among geographical regions.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D016106 Methicillin Resistance Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative. Methicillin-Resistant,Methicillin Resistant,Resistance, Methicillin
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Beta-lactamase activity of anaerobic bacteroides strains isolated from clinical samples and their susceptibility to antimicrobial agents.
January 1999, Drug metabolism and drug interactions,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples.
January 2021, Scientific reports,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Impact of antimicrobial exposure and beta-lactamase-producing bacteria on salivary beta-lactamase activity in infancy.
November 2004, International journal of antimicrobial agents,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Extended-spectrum beta-lactamase-producing bacteria isolated from companion animals.
November 2007, The Veterinary record,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Presence of beta-lactamase-producing bacteria and beta-lactamase activity in abscesses.
July 1986, American journal of clinical pathology,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis.
October 2004, Oral microbiology and immunology,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Current antimicrobial susceptibility testing for beta-lactamase-producing Enterobacteriaceae in clinical settings.
September 2018, Journal of microbiological methods,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
October 2007, Journal of chemotherapy (Florence, Italy),
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Antimicrobial Susceptibility Profile of Extended Spectrum β-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples.
January 2014, Infectious diseases,
Toyoko Oguri, and Jun Igari, and Keiichi Hiramatsu, and Akira Watanabe, and Matsuhisa Inoue, and Michiko Abe, and Nobuhisa Yamane, and Masanori Aihara, and Hajime Hashimoto, and
Antimicrobial susceptibility of bacteria isolated from inpatients and outpatients urine samples.
January 2010, Medicinski arhiv,
Copied contents to your clipboard!